Stocktoria
NewGenIvf Group Ltd NIVF
Nasdaq · XNAS · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2022-02-15
NewGenIvf Group Ltd statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 4.0% | 33.6% | 32.7% | 25.9% |
| Operating margin | -45.2% | -21.4% | 0.8% | 6.7% |
| Net margin | 41.7% | -9.7% | 2.5% | 7.7% |
| FCF margin | -46.7% | -153.1% | -35.7% | 27.2% |
| Return on assets | 30.2% | -14.7% | 2.9% | 15.8% |
| Return on equity | 37.1% | 35.4% | 3.5% | 81.5% |
| Current ratio | 3.12 | 1.17 | 2.19 | 0.94 |
| Revenue growth | 336.3% | 5.8% | -13.6% | — |
Source: SEC EDGAR filings · CIK 0001981662 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.